Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer

被引：0
|
作者：
Krieger, G
机构：
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2001年 / 177卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：316 / 318
页数：3
相关论文
共 50 条
  • [11] Fluorouracil, Leucovorin, and Irinotecan Plus Either Sunitinib or Placebo in Metastatic Colorectal Cancer: A Randomized, Phase III Trial
    Carrato, Alfredo
    Swieboda-Sadlej, Anna
    Staszewska-Skurczynska, Marzanna
    Lim, Robert
    Roman, Laslo
    Shparyk, Yaroslav
    Bondarenko, Igor
    Jonker, Derek J.
    Sun, Yan
    De la Cruz, Jhony A.
    Williams, J. Andrew
    Korytowsky, Beata
    Christensen, James G.
    Lin, Xun
    Tursi, Jennifer M.
    Lechuga, Maria J.
    Van Cutsem, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (10) : 1341 - 1347
  • [12] 5-fluorouracil plus calcium leucovorin and irinotecan in the treatment of metastatic colorectal cancer: Phase II study
    Salek, T.
    Mego, M.
    Mardiak, J.
    Porsok, S.
    Hlavata, Z.
    Dolinsky, J.
    Palacka, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 86 - 86
  • [13] Cost-effectiveness of Capecitabine plus Irinotecan Versus Leucovorin plus Fluorouracil plus Irinotecan in the Second-line Treatment of Metastatic Colorectal Cancer in China
    Wu, Qiuji
    Zhang, Pengfei
    Wang, Xinyuan
    Zhang, Mengxi
    Liao, Weiting
    Li, Qiu
    CLINICAL THERAPEUTICS, 2020, 42 (11) : 2148 - +
  • [14] Recommendation for caution with irinotecan, fluorouracil, leucovorin for colorectal cancer
    Klautke, G
    Fietkau, R
    STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 (03) : 163 - 164
  • [15] First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer
    Claus-Henning Köhne
    Ralf Hofheinz
    Laurent Mineur
    Henry Letocha
    Richard Greil
    Josef Thaler
    Eva Fernebro
    Erick Gamelin
    Lucy DeCosta
    Meinolf Karthaus
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 65 - 72
  • [16] A Randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
    Goldberg, RM
    Sargent, DJ
    Morton, RF
    Fuchs, CS
    Ramanathan, RK
    Williamson, SK
    Findlay, BP
    Pitot, HC
    Alberts, SR
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (01) : 23 - 30
  • [17] First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer
    Koehne, Claus-Henning
    Hofheinz, Ralf
    Mineur, Laurent
    Letocha, Henry
    Greil, Richard
    Thaler, Josef
    Fernebro, Eva
    Gamelin, Erick
    DeCosta, Lucy
    Karthaus, Meinolf
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (01) : 65 - 72
  • [18] OUR EXPERIENCE WITH IRINOTECAN AND BOLUS FLUOROURACIL/LEUCOVORIN IN THE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER
    Davidov, Deyan
    JOURNAL OF IMAB, 2009, 15 (01): : 49 - 52
  • [19] Bevacizumab in combination with irinotecan plus fluorouracil plus leucovorin chemotherapy prolongs survival but increases adverse events in people with metastatic colorectal cancer
    Choti, MA
    CANCER TREATMENT REVIEWS, 2004, 30 (08) : 715 - 720
  • [20] FLUOROURACIL AND LEUCOVORIN FOR METASTATIC COLORECTAL-CANCER
    ERLICHMAN, C
    JOURNAL OF CHEMOTHERAPY, 1990, 2 : 38 - 40
12345